Xiaobin Zhou

Xiaobin Zhou


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2019 in International Journal of Nursing Practice
Verified
Journal Article
Closed access
PDF file
HLHaihua Liu
Haihua Liu
XZXiaobin Zhou
Xiaobin Zhou
GYGuoyi Yu
Guoyi Yu
XSXiao Sun
Xiao Sun

1 December 2017 in Medicine
Verified
Journal Article
Open access
XZXiaoyan Zhu
Xiaoyan Zhu
XZXiaobin Zhou
Xiaobin Zhou
YZYuan Zhang
Yuan Zhang
XSXiao Sun
Xiao Sun
HLHaihua Liu
Haihua Liu
YZYingying Zhang
Yingying Zhang
Survival analysis methods have gained widespread use in the filed of oncology. For achievement of reliable results, the methodological process and report quality is crucial. This review provides the first examination of methodological characteristics and reporting quality of survival analysis in articles published in leading Chinese oncology journals. To examine methodological and reporting quality of survival analysis, to identify some common deficiencies, to desirable precautions in the analysis, and relate advice for authors, readers, and editors. A total of 242 survival analysis articles were included to be evaluated from 1492 articles published in 4 leading Chinese oncology journals in 2013. Articles were evaluated according to 16 established items for proper use and reporting of survival analysis. The application rates of Kaplan–Meier, life table, log-rank test, Breslow test, and Cox proportional hazards model (Cox model) were 91.74%, 3.72%, 78.51%, 0.41%, and 46.28%, respectively, no article used the parametric method for survival analysis. Multivariate Cox model was conducted in 112 articles (46.28%). Follow-up rates were mentioned in 155 articles (64.05%), of which 4 articles were under 80% and the lowest was 75.25%, 55 articles were100%. The report rates of all types of survival endpoint were lower than 10%. Eleven of 100 articles which reported a loss to follow-up had stated how to treat it in the analysis. One hundred thirty articles (53.72%) did not perform multivariate analysis. One hundred thirty-nine articles (57.44%) did not define the survival time. Violations and omissions of methodological guidelines included no mention of pertinent checks for proportional hazard assumption; no report of testing for interactions and collinearity between independent variables; no report of calculation method of sample size. Thirty-six articles (32.74%) reported the methods of independent variable selection. The above defects could make potentially inaccurate, misleading of the reported results, or difficult to interpret. There are gaps in the conduct and reporting of survival analysis in studies published in Chinese oncology journals, severe deficiencies were noted. More endorsement by journals of the report guideline for survival analysis may improve articles quality, and the dissemination of reliable evidence to oncology clinicians. We recommend authors, readers, reviewers, and editors to consider survival analysis more carefully and cooperate more closely with statisticians and epidemiologists.

16 June 2010 in Journal of Psychoeducational Assessment
Verified
Journal Article
Closed access
PDF file
XZXiaobin Zhou
Xiaobin Zhou
JZJianjun Zhu
Jianjun Zhu
LWLawrence G. Weiss
Lawrence G. Weiss
This study investigated the Wechsler Performance IQ (PIQ) or Perceptual Reasoning Index (PRI)/ Perceptual Organization Index (POI) change over time and its relation to ability levels. PIQ or PRI/ POI was analyzed because of the known sensitivity of nonverbal scales to the Flynn effect. Scores were analyzed using two methods. First, analysis of covariance was applied to the combination of four representative samples of individuals who were administered the following pairs of Wechsler batteries in counterbalanced order: Wechsler Preschool and Primary Scale of Intelligence—Revised (WPPSI-R) and WPPSI-III (N = 174), Wechsler Intelligence Scale for Children — Third Edition (WISC-III) and WISC-IV (N = 239), Wechsler Adult Intelligence Scale—Revised (WAIS-R) and WAIS-III (N = 191), and WAIS-III and WAIS-IV ( N = 240). Second, equal percentile equating was applied to each of the samples independently. Although the two methods produced different patterns of results, both methods showed some evidence of variation in the magnitude of the Flynn effect across ability levels. These results call into question the practice of adjusting IQs based on an average expected Flynn effect in routine clinical evaluations.

29 November 2018 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
XSXiao Sun
Xiao Sun
XZXiaobin Zhou
Xiaobin Zhou
YYYan Yu
Yan Yu
HLHaihua Liu
Haihua Liu
Systematic reviews (SRs) and meta-analyses (MAs) are distillation of current best available evidence, but are potentially prone to bias. The bias of SRs and MAs comes from sampling bias, selection bias and within study bias. So, their reporting quality is especially important as it may directly influence their utility for clinicians, nurses, patients and policy makers. The SRs and MAs on nursing interventions in patients with Alzheimer’s disease (AD) have been increasingly published over the past decade, but the reporting quality of article has not been evaluated after the introduction of Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) Statement. According to the inclusion and exclusion criteria, we searched the databases including PubMed, EMBASE and The Cochrane Library from inception through October 16th 2018. Two reviewers independently selected articles and extracted data. The PRISMA checklist was adopted to evaluate reporting quality. Comparisons were made between studies published before (2001–2009) and after (2011–2018) its introduction. A total of 77 eligible articles, 18 (23.4%) were published before the PRISMA Statement and 59 (76.6%) were published afterwards. There was higher score after publication of the PRISMA Statement than before (20.83 ± 3.78 vs 17.11 ± 4.56, P < 0.05). There was an improvement in the following items after the PRISMA statement was released (P < 0.05): title (item 1, 50.0% vs 74.6%, OR = 3.10, 95CI%: 1.00–9.61), search (item8, 27.8% vs 57.6%,OR = 3.25, 95CI%: 1.14–9.28), study selection (item 9, 44.4% vs 81.4%,OR = 6.28, 95CI%: 1.93–20.37), Data collection process (item 10, 50.0% vs 76.3%,OR = 3.45, 95CI%:1.10–10.84), risk of bias in individual studies (item 12, 50.0% vs 83.1%, OR = 5.78, 95CI%:1.71–19.52), risk of bias across studies (item15, 5.6% vs 28.8%,OR = 3.60, 95CI%:1.04–12.43), study characteristics (item 18, 77.8% vs 98.3%, OR = 28.13, 95CI%:3.35-236.19), risk of bias with studies (item 19, 50.0% vs 83.1%, OR = 5.78, 95CI%:1.71-19.52), results in individual studies (item 20, 72.2% vs 94.9%, OR = 11.09, 95CI%:1.99–61.82), conclusions (item 26, 77.8% vs 98.3%, OR = 28.13, 95CI%:3.35–236.19). After controlling for the confounding factors, there were higher PRISMA score for systematic reviews including meta-analyses, protocol or registration, can’t answer of RCT, journal source of SCI (Science Citation Index), manuscript length > 13 page and funding support. Since the publication of the PRISMA Statement, there has been an improvement in the quality of reporting of SRs and MAs on nursing interventions in patients with AD. More endorsement by journals of the report guideline for SRs/MAs may improve articles reporting quality, and the dissemination of reliable evidence to nurses. We recommend authors, readers, reviewers, and editors to become more acquainted with and to more strictly adhere to the PRISMA checklist.

25 January 2022 in PeerJ
Verified
Journal Article
Open access
PDF file
JZJing Zhou
Jing Zhou
JLJianqiang Li
Jianqiang Li
JZJingao Zhang
Jingao Zhang
BGBo Geng
Bo Geng
YCYao Chen
Yao Chen
XZXiaobin Zhou
Xiaobin Zhou
Background: A journal’s impact factor (IF) and total citations are often used as indicators of its publication quality. Furthermore, journals that require authors to abide by reporting guidelines or conduct trial registration generally have a higher quality of reporting. In this study, we sought to explore the potential associations between the enforcement of reporting guidelines or trial registration and a surgical journal’s IF or total citations in order to find new approaches and ideas to improve journal publication quality. Methods: We examined surgical journals from the 2018 Journal Citation Report’s Expanded Scientific Citation Index to quantify the use of reporting guidelines or study registration. We reviewed the “instructions for authors” from each journal and used multivariable linear regression analysis to determine which guidelines were associated with the journal IF and total citations. The dependent variable was the logarithm base 10 of the IF in 2018 or the logarithm base 10 of total citations in 2018 (the results were presented as geometric means, specifically the ratio of the “endorsed group” results to “not endorsed group” results). The independent variable was one of the requirements (endorsed and not endorsed). Models adjust for the publication region, language, start year, publisher and journal size (only used to adjust total citations). Results: We included 188 surgical journals in our study. The results of multivariable linear regression analysis showed that journal IF was associated (P < 0.01) with the following requirements: randomized controlled trial (RCT) registration (geometric means ratio (GR) = 1.422, 95% CI [1.197–1.694]), Consolidated Standards of Reporting Trials (CONSORT) statement (1.318, [1.104–1.578]), Preferred Reporting Items for Systematic Reviews Meta-Analyses (PRISMA) statement (1.390, [1.148–1.683]), Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement (1.556, [1.262–1.919]), Standards for Reporting Diagnostic Accuracy (STARD) statement (1.585, [1.216–2.070]), and Meta-analysis of Observational Studies in Epidemiology (MOOSE) statement (2.113, [1.422–3.133]). We found associations between the endorsement of RCT registration (GR = 1.652, 95% CI [1.268–2.153]), CONSORT (1.570, [1.199–2.061]), PRISMA (1.698, [1.271–2.270]), STROBE (2.023, [1.476–2.773]), STARD (2.173, [1.452–3.243]), and MOOSE statements (2.249, [1.219–4.150]) and the number of total citations. Conclusion: The presence of reporting guidelines and trial registration was associated with higher IF or more total citations in surgical journals. If more surgical journals incorporate these policies into their submission requirements, this may improve publication quality, thus increasing their IF and total citations.

15 May 2018 in Disease Markers
Verified
Journal Article
Open access
PDF file
XSXiao Sun
Xiao Sun
XZXiaobin Zhou
Xiaobin Zhou
YZYuan Zhang
Yuan Zhang
XZXiaoyan Zhu
Xiaoyan Zhu
HLHaihua Liu
Haihua Liu
Background. It is reported that miRNAs are aberrantly expressed in patients with pancreatic cancer. However, the diagnostic value of miRNAs in pancreatic cancer remains controversial. The meta-analysis was to access diagnostic accuracy of miRNAs in pancreatic cancer. Methods. PubMed, Scopus, Web of Science, Chinese National Knowledge Infrastructure (CNKI), WANFANG Data, China Biomedical Literature Database (CBM), and VIP databases were retrieved up to June 30, 2016, to collect articles concerning the diagnosis of miRNAs in pancreatic cancer. The methodological quality of each study was assessed by the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). This meta-analysis was conducted using RevMan5.0, MetaDiSc 1.4, and Stata 12.0 software. Results. There are 40 articles including 109 studies. The pooled SEN was 0.81 (95% CI, 0.80–0.82), the pooled SPE was 0.78 (95% CI, 0.77–0.79), the pooled +LR was 3.32 (95% CI, 2.92–3.80), the pooled −LR was 0.27 (95% CI, 0.24–0.31), the pooled DOR was 14.56 (95% CI, 11.55–18.34), and pooled AUC was 0.86 (95% CI, 0.84–0.88). Discussion. This meta-analysis demonstrated that miRNA makes a significant impact in the pancreatic cancer diagnosis with a high SEN and SPE, particularly using multiple miRNAs.